SNBL USA delivers high-quality preclinical data to our clients in a highly time effective manner, with particularly in-depth expertise in non-human primate research.
Furthermore, SNBL USA has established specialized services focused on:
Characterization (pharmacology and toxicology) of biologics
Development of CNS-focused models, including learning and behavior
Expertise in developmental and reproductive toxicology (DART)
SNBL USA has several key assets that enable its team to provide clients with precision science and high quality data. These assets include:
The facility’s established colonies of small animals and non-human primates enable rapid initiation of projects
Recognizing the critical need that preclinical data play in helping our clients to advance their drug development programs, we are committed to providing clients with timely results, delivering study reports within nine weeks of study completion.
Proprietary technologies – SNBL has also pioneered the use of new proprietary technologies such as an in-house developed procedure cage. The procedure cage is designed to provide a less stressful environment for the NHP, and safer handling for staff, thereby decreasing study variability and noise while also enhancing overall animal welfare.
Study direction team has over 35+ years of combined experience directing NHP DART studies
Supervisory technician team averages 10+ years of experience managing NHP DART studies
50+ NHP DART studies conducted to date, including
ePPND or EFD/PPND combination studies
Stand-alone EFD studies
Repeat dose studies with fertility endpoints
Histopathology of reproductive organs
SNBL USA has not received any reviews.
SNBL USA has not received any endorsements.